Javier Ros

1.7k total citations
72 papers, 798 citations indexed

About

Javier Ros is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Javier Ros has authored 72 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Javier Ros's work include Colorectal Cancer Treatments and Studies (41 papers), Cancer Immunotherapy and Biomarkers (24 papers) and Genetic factors in colorectal cancer (22 papers). Javier Ros is often cited by papers focused on Colorectal Cancer Treatments and Studies (41 papers), Cancer Immunotherapy and Biomarkers (24 papers) and Genetic factors in colorectal cancer (22 papers). Javier Ros collaborates with scholars based in Spain, Italy and Palestinian Territory. Javier Ros's co-authors include Élena Elez, Josep Tabernero, Iosune Baraibar, Francesc Salvà, N. Saoudi Gonzalez, Giulia Martini, Davide Ciardiello, Guillem Argilés, Ariadna García and Nuria Mulet and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Javier Ros

63 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Javier Ros Spain	17	573	232	203	182	177	72	798
Rangaswamy Govindarajan United States	12	430 0.8×	152 0.7×	427 2.1×	189 1.0×	130 0.7×	39	973
Elena Ongaro Italy	15	495 0.9×	153 0.7×	273 1.3×	172 0.9×	304 1.7×	38	878
María Carmen Riesco Martínez Spain	15	413 0.7×	94 0.4×	129 0.6×	94 0.5×	125 0.7×	42	626
May Cho United States	17	507 0.9×	175 0.8×	156 0.8×	120 0.7×	222 1.3×	57	834
Takao Yokoe Japan	18	544 0.9×	206 0.9×	200 1.0×	317 1.7×	122 0.7×	104	1.1k
Mirian Brink Netherlands	14	477 0.8×	409 1.8×	442 2.2×	201 1.1×	136 0.8×	30	1.1k
Gianluca Mauri Italy	17	853 1.5×	454 2.0×	280 1.4×	342 1.9×	277 1.6×	40	1.2k
Niels Henrik Holländer Denmark	13	481 0.8×	92 0.4×	314 1.5×	383 2.1×	119 0.7×	44	838
Yesilda Balavarca Germany	19	487 0.8×	143 0.6×	275 1.4×	146 0.8×	195 1.1×	37	929
Kalliopi Andrikou Italy	16	534 0.9×	123 0.5×	189 0.9×	223 1.2×	287 1.6×	54	837

Countries citing papers authored by Javier Ros

Since Specialization

Citations

This map shows the geographic impact of Javier Ros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Ros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Ros more than expected).

Fields of papers citing papers by Javier Ros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Ros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Ros. The network helps show where Javier Ros may publish in the future.

Co-authorship network of co-authors of Javier Ros

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Ros. A scholar is included among the top collaborators of Javier Ros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Ros. Javier Ros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ros, Javier, Albert Gil‐Vila, Debayan Datta, et al.. (2025). Frequent genetic alterations in myositis autoantigen genes in cancer-associated dermatomyositis. Annals of the Rheumatic Diseases. 85(3). 519–533.

Tosi, Federica, Gianluca Mauri, Erica Bonazzina, et al.. (2025). Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies. Drugs. 86(1). 37–57. 1 indexed citations

Taı̈eb, Julien, Margherita Ambrosini, Sara Lonardi, et al.. (2025). Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer. 13(1). e010424–e010424. 2 indexed citations

Prisciandaro, Michele, Javier Ros, Mario Mandalà, et al.. (2025). 723O Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: Final results of the PEGASUS trial. Annals of Oncology. 36. S474–S474. 1 indexed citations

Baraibar, Iosune, N. Saoudi Gonzalez, Javier Ros, et al.. (2024). Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer. International Journal of Molecular Sciences. 25(13). 6967–6967. 6 indexed citations

Ros, Javier, Iosune Baraibar, N. Saoudi Gonzalez, et al.. (2024). Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver. International Journal of Molecular Sciences. 25(6). 3304–3304. 21 indexed citations

Barretta, Francesco, Francesca Corti, Sara Lonardi, et al.. (2023). Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 11(1). e005493–e005493. 13 indexed citations

Moretto, Roberto, Marco Maria Germani, Javier Ros, et al.. (2023). Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy. JCO Precision Oncology. 7(7). e2300255–e2300255. 5 indexed citations

Ros, Javier, et al.. (2022). 374P Influence of sex on safety and efficacy in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with encorafenib-cetuximab +/-binimetinib (E-C+/-B). Annals of Oncology. 33. S707–S707.

10.

Mirallas, Oriol, Diana Valbuena, Elena Martínez‐Sáez, et al.. (2022). 290P Potential enrichment strategies for next-generation sequencing (NGS) in primary brain cancers (pBCs) in a clinical series according to ESMO scale for clinical actionability of molecular targets (ESCAT). Annals of Oncology. 33. S671–S672. 1 indexed citations

11.

Gonzalez, N. Saoudi, et al.. (2022). New Insights into Adjuvant Therapy for Localized Colon Cancer. Hematology/Oncology Clinics of North America. 36(3). 507–520. 1 indexed citations

12.

Kagawa, Yoshinori, Élena Elez, Jesús García‐Foncillas, et al.. (2021). Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for RAS Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study. Clinical Cancer Research. 27(9). 2515–2522. 45 indexed citations

13.

Randon, Giovanni, Rossana Intini, Chiara Cremolini, et al.. (2021). Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer. European Journal of Cancer. 161. 90–98. 15 indexed citations

14.

Ros, Javier, Iosune Baraibar, Giulia Martini, et al.. (2021). The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer. Current Treatment Options in Oncology. 22(12). 113–113. 14 indexed citations

15.

Elez, Élena, Javier Ros, Giulia Martini, et al.. (2021). LBA-3 Integrated analysis of cell-free DNA (cfDNA) BRAF mutant allele fraction (MAF) and whole exome sequencing in BRAFV600E metastatic colorectal cancer (mCRC) treated with BRAF-antiEGFR +/- MEK inhibitors. Annals of Oncology. 32. S226–S227. 10 indexed citations

16.

Alonso, Guzmán, Javier Ros, Helena Verdaguer, et al.. (2021). 6P Circulating tumor DNA (ctDNA) next generation sequencing (NGS): Molecular prescreening for tailoring treatment in clinical trials. Annals of Oncology. 32. S1346–S1348. 1 indexed citations

17.

Verdaguer, Helena, Elvira Buxó, N. Saoudi Gonzalez, et al.. (2020). 1558P Pancreatic cancer (PC) in patients (pts) younger than 50 years: Clinical outcomes and actionable genomic/genetic alterations. Annals of Oncology. 31. S951–S951. 1 indexed citations

18.

Gonzalez, N. Saoudi, María Vieito, Irene Braña, et al.. (2020). 380P Ten-year experience of the Vall d’Hebron Institute of Oncology early drug development unit (VHIO-UITM) treating patients (pts) with primary CNS tumours (pCNS). Annals of Oncology. 31. S403–S403.

19.

Kagawa, Yoshinori, Jesús García‐Foncillas, Hideaki Bando, et al.. (2020). O-21 METABEAM study: Combined analysis of concordance studies between liquid and tissue biopsies for RAS mutations in colorectal cancer patients with single metastatic sites. Annals of Oncology. 31. 239–240.

20.

Selva-O’Callaghan, Albert, et al.. (2019). Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes. Neuromuscular Disorders. 29(11). 819–825. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact